Image Processing Reference
In-Depth Information
5.
Demaerel, P., Johannik, K., Van Hecke, P., van Ogeval, C., Verellen, S., Marchal,
G., Plets, C., Goffin, J., Van Calenbergh, F., Lamens, M., and Baert, A.L. (1991).
Localization of 1 H-MR spectroscopy in fifty cases newly diagnosed intracranial
tumors, J. Comput. Assist. Tomogr. 15: 67-76.
6.
Williams, S.R., Crockard, H.A., and Gaudian, D.G. (1989). Cerebral ischemia
studied by nuclear magnetic resonance spectroscopy. Cerebrovasc. Brain Metab.
Rev. 1: 91-114.
7.
Matthews, P.M., Andermann, F., and Arnold, D.L. (1990). A proton magnetic
resonance spectroscopy study of focal epilepsy in humans. Neuroradiology, 40:
985-989.
8.
Hugg, J.W., Laxer, K.D., Matson, G.B., Maudseley, A.A., and Weiner, M.W.
(1992). Neuron loss localizes human focal epilepsy by in-vivo proton MR spec-
troscopy imaging. Ann. Neurol. 42: 2011-2018.
9.
Matthews, P.M., Francis, G., Antel, J., and Arnold, D.L. (1991). Proton magnetic
resonance spectroscopy for metabolic characterization of plaques in multiple
sclerosis. Neurology, 41: 1251-1256.
10.
Wolinsky, J.S., Narayana, P.A., and Fenstermacher, M.J. (1990). Proton magnetic
resonance spectroscopy in multiple sclerosis. Neurology, 40: 1764-1769.
11.
Peeling, J. and Sutherland, G. (1992). High-resolution 1 H-NMR spectroscopy
studies of extracts of human cerebral neoplasms. Magn. Reson. Med . 24: 123-136.
12.
Preul, M.C., Olivier, A., Pokrupa, R., and Arnold, D.L. (1996). Accurate non-
invasive diagnosis of human brain tumors by using 1 H magnetic resonance
spectroscopy. Nature Med . 2: 323-325.
13.
Garcia-Martin, M.L., Garcia-Espinosa, M.A., and Cerdan, S. (1998). Biochemistry
detectable by MRS, in Syllabus. Methodology, Spectroscopy and Clinical MRI .
15th Annual Scientific Meeting. Geneva. September 17-20.
14.
Emsley, J.W., Feeney, J., and Sutcliffe, L.H. (1991). Progress in nuclear magnetic
resonance spectroscopy. Progress in NMR spectroscopy . 23: 211-258.
15.
de Graaf, A.A. and Bovée, W.M.M.J. (1990). Improved quantification of in vivo
1 H NMR spectra by optimization of signal acquisition and processing and by
incorporation of prior knowledge into spectral fitting. Magnetic Resonance in
Medicine . 15: 305-319.
16.
van Rijen, P.C., Verheul, H.B., and van Echteld, C.J.A. (1991). Effects of dex-
tromethorphan on rat brain during ischemia and reperfusion assessed by magnetic
resonance spectroscopy. Stroke, 22: 343-350.
17.
Berkelbach van der Sprenkel, J.W., Luyten, P.R., van Rijen, P.C., Tulleken, C.A.,
and den Hollander, J.A. (1988). Cerebral lactate detected by regional proton
magnetic resonance spectroscopy in a patient with cerebral infarction. Stroke, 19:
1556-1560.
18.
Grossman, R.I., Lenkiski, R.E., Ramer, K.N., Gonzaales-Scarano, F., and Cohen,
J.A. (1992). MR proton spectroscopy in multiple sclerosis. AJNR . 13: 1535-1543.
19.
Ross, B.D., Radda, G.K., Gadian, D.G., Rocker, G., Esiri, M., and Falconer-Smith,
J. (1981). Examination of a case of suspected McArdle's Syndrome by 31P nuclear
magnetic resonance. N. Engl. J. Med. 304: 1338-1342.
20.
Newman, R.J., Bore, P.J., Chan, L., Gadian, D.G., Styles, P., Taylor D., and Radda,
G.K. (1982). Nuclear magnetic resonance studies of forearm muscle in Duchenne
dystrophy. Br. Med. J Clin. Res. Ed. 284: 1072-1074.
21.
Mierisova, S. and Ala-Korpela, M. (2001). MR spectroscopy quantitation: a review
of frequency-domain methods, NMR in Biomed . 14: 247-259.
Search WWH ::




Custom Search